Hinge Health Inc - Class A
Research Hinge Health Inc - Class A (HNGE) on Bullrun: valuation model: 36.1% overvalued, market cap USD 8.41B, P/E 80.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHNGE
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Valuation signal36.1% overvalued
- Market capUSD 8.41B
- P/E80.7
- Financial periodQ2 2026
- RevenueUSD 212.82M
- Net incomeUSD 43.69M
- Free cash flowUSD 99.56M
- Gross margin86.4%
Valuation Snapshot
Bullrun's latest valuation model marks Hinge Health Inc - Class A as 36.1% overvalued; latest market cap is USD 8.41B; P/E is 80.7.
Peer valuation comparison
Latest P/E is 80.71x versus a Healthcare sector median of 24.6x (228.1% above).
Latest P/E is 80.71x versus a United States median of 23.85x (238.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 587.86M | -USD 528.26M | USD 170.73M | 79.6% | -7.77 | USD 208.00M | USD 8.04M | USD 178.66M |
| FY2024 | USD 390.40M | -USD 11.93M | USD 47.96M | 76.8% | -0.88 | USD 300.79M | USD 11.07M | -USD 434.57M |
| FY2023 | USD 292.73M | -USD 108.14M | -USD 65.89M | 66.3% | -8.31 | USD 234.95M | USD 15.73M | -USD 423.99M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 8.41B | 80.7 | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.68B | n/a | n/a | n/a |
About Hinge Health Inc - Class A
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers.
ETFs that hold Hinge Health Inc - Class A
Hinge Health Inc - Class A is one of the ten largest holdings of 2 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| BIT Global Technology Leaders | 4.21% | 0.46% |
| Global X Telemedicine & Digital Health ETF D | 3.96% | 0.68% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Hinge Health Inc - Class A overvalued or undervalued?
Bullrun's valuation model currently marks Hinge Health Inc - Class A as 36.1% overvalued.
What is Hinge Health Inc - Class A's market cap?
Hinge Health Inc - Class A's market capitalization is USD 8.41B.
What is Hinge Health Inc - Class A's P/E ratio?
Hinge Health Inc - Class A's price-to-earnings (P/E) ratio is 80.7.
What does Hinge Health Inc - Class A do?
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.